Autoimmune cytopenia does not predict poor prognosis in chronic lymphocytic leukemia/small lymphocytic lymphoma

被引:67
作者
Kyasa, MJ
Parrish, RS
Schichman, SA
Zent, CS
机构
[1] CAVHS, Dept Med, Div Hematol Oncol, Little Rock, AR USA
[2] UAMS, Div Biometry, Little Rock, AR USA
[3] UAMS, Dept Biostat, Little Rock, AR USA
[4] CAVHS, Pathol & Lab Med Serv, Little Rock, AR USA
[5] UAMS, Dept Pathol, Little Rock, AR USA
关键词
CLL/SLL; autoimmune; hemolytic; anemia; thrombocytopenia;
D O I
10.1002/ajh.10369
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) is characterized by an acquired immune defect that can cause autoimmune complications, including anemia and thrombocytopenia. We conducted an observational study of the epidemiology, clinical presentation and significance of autoimmune complications of CLL/SLL in 132 patients from a large population (>45,000 veterans), in which at least 90% of patients with CLL/SLL have been previously identified. Over a period of 12.5 years, 12 patients (9.1%) had autoimmune complications; of these, 6 (4.5%) had autoimmune hemolytic anemia (AIHA), 5 (3.8%) had immune thrombocytopenia (ITP), and 1 (0.8%) had pure red blood cell aplasia (PRBA). All 6 cases of AIHA had a positive direct immunoglobulin test for IgG and C3d. In 6 patients, CLL/SLL was an incidental finding at the time of presentation with autoimmune cytopenia. Nine out of 10 patients responded to immunosuppressive therapy, which was complicated by serious infection in 7 cases, one of which was fatal. The major cause of mortality in patients with autoimmune complications of CLL/SLL was secondary malignancy. Survival of patients with immune cytopenia was not significantly different from CLL/SLL patients without immune cytopenia. Among patients with anemia or thrombocytopenia, mortality was significantly higher in those with bone marrow failure compared to an autoimmune etiology. We show that in a non-referred population with a high incidence of CLL/SLL, autoimmune cytopenia can occur early in the natural history of the disease. These data suggest that the Rai and Binet classifications for CLL need to be modified for patients with autoimmune cytopenia. Published 2003 Wiley-Liss, Inc.(dagger).
引用
收藏
页码:1 / 8
页数:8
相关论文
共 31 条
[1]  
Bartik MM, 1998, SEMIN ONCOL, V25, P27
[2]  
BERGSAGEL DE, 1967, CAN MED ASSOC J, V96, P1615
[3]  
BINET JL, 1981, CANCER-AM CANCER SOC, V48, P198, DOI 10.1002/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO
[4]  
2-V
[5]   Successful treatment of steroid and cyclophosphamide-resistant hemolysis in chronic lymphocytic leukemia with rituximab [J].
Chemnitz, J ;
Draube, A ;
Diehl, V ;
Wolf, J .
AMERICAN JOURNAL OF HEMATOLOGY, 2002, 69 (03) :232-233
[6]   GUIDELINES FOR CLINICAL PROTOCOLS FOR CHRONIC LYMPHOCYTIC-LEUKEMIA - RECOMMENDATIONS OF THE NATIONAL-CANCER-INSTITUTE-SPONSORED-WORKING-GROUP [J].
CHESON, BD ;
BENNETT, JM ;
RAI, KR ;
GREVER, MR ;
KAY, NE ;
SCHIFFER, CA ;
OKEN, MM ;
KEATING, MJ ;
BOLDT, DH ;
KEMPIN, SJ ;
FOON, KA .
AMERICAN JOURNAL OF HEMATOLOGY, 1988, 29 (03) :152-163
[7]   National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: Revised guidelines for diagnosis and treatment [J].
Cheson, BD ;
Bennett, JM ;
Grever, M ;
Kay, N ;
Keating, MJ ;
OBrien, S ;
Rai, KR .
BLOOD, 1996, 87 (12) :4990-4997
[8]  
Cheson BD, 2001, CHRONIC LYMPHOID LEU, P231
[9]  
Diehl LF, 1998, SEMIN ONCOL, V25, P80
[10]   When and how to treat chronic lymphocytic leukemia. [J].
Dighiero, G ;
Binet, J .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (24) :1799-1801